[Cardioverter-defibrillator in the treatment of arrhythmia induced by trastuzumab used in the adjuvant setting in a patient with positive human epidermal growth factor receptor type-2 breast cancer]

Autor:	Grzegorz, Piotrowski, Rafał, Gawor, Robert, Słomka, Maciej, Banasiak, Paweł, Strzelecki, Zenon, Gawor, Piotr, Potemski
Rok vydání:	2012
Předmět:	Adult Fatal Outcome Echocardiography Receptor ErbB-2 Humans Antineoplastic Agents Arrhythmias Cardiac Breast Neoplasms Female Trastuzumab Antibodies Monoclonal Humanized Defibrillators Implantable Follow-Up Studies
Zdroj:	Kardiologia polska. 70(7)
ISSN:	1897-4279
Popis:	A case of a 36-year old woman with HER2-positive early breast cancer treated with adjuvant trastuzumab left ventricle dysfunction and cardiac arrest in ventricular fibrillation mechanism is presented. After having been successfully resuscitated, trastuzumab therapy was withheld, pharmacotherapy (beta-blocker, ACE-I) implemented and ICD was implanted. Echocardiography performed 6 months later, revealed normal systolic function of the left ventricle. The patient died despite further oncologic treatment due to progression of the disease. The authors discuss the approach to this dramatic but lone cardiac side effect of trastuzumab treatment.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::205d80cc3988fc0961cc9ecce55d0b78 https://pubmed.ncbi.nlm.nih.gov/22825958 Zobrazit plný text záznamu